Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Oncology devices play a major role in healthcare, owing to factors such as increasing incidence of cancer in Latin America. For instance, according to the Global Cancer Observatory’s 2019 report, in Chile, around 53,365 new cases of cancer were recorded in 2018, and around 28,443 individuals died due to cancer in 2018. Moreover, according to the same source, in 2018, around 6,576 people suffered from prostate cancer which was major type of cancer among all the types of cancer cases observed in Chile.

Furthermore, key companies are focused on research and development of technologically advanced devices for the treatment of cancer due to increase in incidence in the region, which is expected to drive the market growth. For instance, in January 2019, Medtronic PLC announced that the Journal of Thoracic Oncology published 12-month results of the NAVIGATE study, the largest, prospective, multicenter trial evaluating electromagnetic navigation bronchoscopy (ENB) procedures using the super Dimension navigation system to aid in lung cancer diagnosis, staging, and treatment. NAVIGATE included a key finding that 65% of the patients diagnosed by physicians with primary lung cancer were at early stages (Stage I or II) of the disease

The Latin America oncology device market size is estimated to be valued at US$ 31.08 million in 2020 and is expected to exhibit a CAGR of 5.5 % over the forecast period (2020-2027).

Figure 1. Latin America Oncology Device Market, by Market Value (US$ Mn), 2016-2027

Latin America Oncology Device  | Coherent Market Insights

The increasing incidence of cancer is driving demand for oncology devices for the treatment of cancer. For instance, according to the International Agency for Research on Cancer’s 2019 report, in Mexico, around 190,667 patients were newly diagnosed with cancer and around 83,476 patients died due to cancer in 2018. According to the same source, breast cancer was the major type of cancer in Mexico with around 27,283 new cases of breast cancer in 2018.

Moreover, according to the International Agency for Research on Cancer’s 2019 report, in Mexico, around 190,667 patients were newly diagnosed with cancer and around 83,476 patients died due to cancer in 2018. According to the same source, breast cancer was the major type of cancer in Mexico with around 27,283 new cases of breast cancer in 2018.

request-sample

Latin America Oncology Device Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 31.08 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.5 % 2027 Value Projection: US$ 45.14 Mn
Geographies covered:
  • Brazil: South East, North East, South, Mid-west, North
  • Mexico
  • Chi
Segments covered:
  • By Chemotherapy Administration: Gravity Chemotherapy Administration, Syringe Chemotherapy Administration, Pump Chemotherapy Administration, Others.
  • By Accessories and consumables: Infusion Sets
    • Venous Access: Ports, Needle.
    • Catheter: CVC, PIC.
    • Needleless Connectors, Syringe Filters, Software.
  • By Age Group:
    • Pediatric: Infant ( from birth to 1 year), Children (4 to 10 years), Teenager/ Adolescent (11 to 19 years)
    • Adults.
  • By End User
    • Private Hospitals/ Clinics: General Hospitals with Oncology Centers, Specialized Hospitals, Specialized Clinics.
    • Public Hospitals / Clinics: General Hospitals with Oncology centers, Hospitals, Clinics.
    • Others: Homecare Settings, Research Institutes.
Companies covered:

Medtronic plc, ACE Medical, VOGT Medical, Becton, Dickinson and Company, Smiths Medical, Inc, Samtronic Industria e Comercio LTDA, Codan Argus AG, B. Braun Melsungen AG, Medical Components, Inc, Fresenius SE & Co. KGaA, Baxter International Inc, EuroLife Healthcare Pvt. Ltd, and Micrel Medical Devices

Growth Drivers:
  • Commercial tie-ups and acquisitions by key players
  • Innovation in clinical research and implementation of advanced technology
  • Increasing incidence of chronic diseases such as cancer
Restraints & Challenges:
  • Radiation devices, infusion devices can cause several side effects on patients undergoing chemotherapy
  • Radiation Therapy causes side effects depending on the type of cancer, its location, the radiation therapy dose, and the patient’s general health.

Latin America Oncology Device Market – Impact of Coronavirus (Covid-19) Pandemic

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in more than 14 million infected individuals worldwide as of July 24, 2020.

Key players operating in the Latin America oncology devices market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials due to irregularities in transportation. Furthermore, distributors are experiencing irregular demand for products from the retailers due to rising incidence of COVID -19.

Moreover, rising Covid-19 infections globally, there are rising consequences such as shortage in essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected patients. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients who may require critical care. Moreover, there is an urgent need for rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others).

Figure 2. Latin America Oncology Device Market Share (%), by Country, 2020

Latin America Oncology Device  | Coherent Market Insights

Among countries, Mexico oncology devices market is expected to exhibit significant growth, owing to increasing distribution agreements between key players to enhance their presence in the country. For instance, in July 2016, Novosanis, a medical device company based in Belgium, announced a distribution partnership with Distribuidora GAP. As part of this agreement, Distribuidora GAP will sell Novosanis’ Colli-PeeTM, a medical device suited for collection of first void urine, in Mexico.  Colli-PeeTM device allows easier and more patient-friendly detection of the Human papillomavirus that can lead to cervical cancer.

Moreover, increasing prevalence of cancer is expected to drive the Chile oncology devices market growth. For instance, in 2015, according to the National Center for Biotechnology Information 2015, the estimated annual incidence of cancer in Chile is around 35,000 new cancer cases per year, with adjusted incidence rates of 226 and 180 per 100,000 male and female inhabitants, respectively.

Key Players

Major players operating in the Latin America oncology device market include Medtronic plc, ACE Medical, VOGT Medical, Becton, Dickinson and Company, Smiths Medical, Inc., Samtronic Industria e Comercio LTDA, Codan Argus AG, B. Braun Melsungen AG, Medical Components, Inc, Fresenius SE & Co. KGaA, Baxter International Inc, EuroLife Healthcare Pvt. Ltd, and Micrel Medical Devices.

Oncology devices are wide range of medical devices used in treatment of cancer. Oncology devices are in-vitro diagnosis and combination device products used in screening, diagnosing, treating, and monitoring premalignant and malignant conditions in patients. Moreover, the increasing number of people suffering from cancer is driving demand for oncology devices. This in turn, is expected to drive the market growth during the forecast period. For instance, in 2019, according to the article published in the Journal of Clinical Oncology in September 2019, in Brazil, the calculated cost per patient suffering from cervical cancer was US$ 7,942 for radiotherapy alone and US$ 8,774 for chemo- radiotherapy.

Market Dynamics

Key companies operating in the market are focusing on product launches and obtaining approvals from regulatory agencies which is expected to facilitate growth of the Latin America oncology devices market during the forecast period. For instance, in December 2017, Varian Medical Systems of Palo Alto, a radiation oncology treatment and software company, received ANVISA approval in Brazil for its Halcyon system. Halcyon simplifies and enhances every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is well suited to treat majority of cancer patients, offer advanced treatments for prostate, breast, head & neck, and many other forms of cancer.

Moreover, government regulating bodies are focused on enhancing digital healthcare and approving new products for treatment of cancer. For instance, in March 2020, MedX Health Corp., a medical device and software company, received regulatory approval from ANVISA to market and sell its SIAscopy on DermSecure skin assessment platform in Brazil. SIAscopy is an imaging technology and a solution for early detection of skin cancer.

Key players in the market are focused on adopting innovative technologies for the development of devices. For instance, in January 2018, ACE Medical launched the AutoMed 3300 Ambulatory Infusion System which is a convenient pump. The pump is fitted with a self-checking system, which will electronically monitor and alert the patient or caregiver of delivery issues via an audible alarm.

Key features of the study:

  • This report provides in-depth analysis of the Latin America oncology devices market and provides market size (US$ Mn), market volume (units), and compound annual growth rate (CAGR) (%) for the forecast period (2020 – 2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the Latin America oncology devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • Key companies covered as a part of this study include Medtronic plc, ACE Medical, VOGT Medical, Becton, Dickinson and Company, Smiths Medical, Inc, Samtronic Industria e Comercio LTDA, Codan Argus AG, B. Braun Melsungen AG, Medical Components, Inc., Fresenius SE & Co. KGaA, Baxter International Inc., EuroLife Healthcare Pvt. Ltd, and Micrel Medical Devices
  • The Latin America oncology devices market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the Latin America oncology devices market

Detailed Segmentation:

  • Latin America Oncology Device Market, By Chemotherapy Administration :
    • Gravity Chemotherapy Administration
    • Syringe Chemotherapy Administration
    • Pump Chemotherapy Administration
    • Others
  • Latin America Oncology Device Market, By Accessories and Consumables :
    • Infusion Sets
    • Venous Access
      • Ports
      • Needle
    • Catheter
      • CVC
      • PIC
    • Needleless Connectors
    • Syringe Filters
    • Software
  • Latin America Oncology Device Market, By Age Group :
    • Pediatric
      • Infant ( from birth to 1 year)
      • Children ( 4 to 10 years )
      • Teenager/ Adolescent ( 11 to 19 years )
    • Adults
  • Latin America Oncology Device Market, By End User :
    • Private Hospitals/ Clinics
      • General Hospitals with Oncology Centers
      • Specialized Hospitals
      • Specialized Clinics
    • Public Hospitals / Clinics
      • General Hospitals with Oncology centers
      • Hospitals
      • Clinics
    • Others
      • Homecare Settings
      • Research Institutes
  • Latin America Oncology Device Market, By Country :
    • Brazil
      • By Chemotherapy Administration :
        • Gravity Chemotherapy Administration
        • Syringe Chemotherapy Administration
        • Pump Chemotherapy Administration
        • Others
      • By Accessories and Consumables :
        • Infusion Sets
        • Venous Access
          • Ports
          • Needle
        • Catheter
          • CVC
          • PIC
        • Needleless Connectors
        • Syringe Filters
        • Software
      • By Age Group :
        • Pediatric
          • Infant ( from birth to 1 year)
          • Children ( 4 to 10 years )
          • Teenager/ Adolescent ( 11 to 19 years )
        • Adults
      • By End User :
        • Private Hospitals/ Clinics
          • General Hospitals with Oncology Centers
          • Specialized Hospitals
          • Specialized Clinics
        • Public Hospitals / Clinics
          • General Hospitals with Oncology centers
          • Hospitals
          • Clinics
        • Others
          • Homecare Settings
          • Research Institutes
    • Mexico
      • By Chemotherapy Administration :
        • Gravity Chemotherapy Administration
        • Syringe Chemotherapy Administration
        • Pump Chemotherapy Administration
        • Others
      • By Accessories and Consumables :
        • Infusion Sets
        • Venous Access
          • Ports
          • Needle
        • Catheter
          • CVC
          • PIC
        • Needleless Connectors
        • Syringe Filters
        • Software
      • By Age Group :
        • Pediatric
          • Infant ( from birth to 1 year)
          • Children ( 4 to 10 years )
          • Teenager/ Adolescent ( 11 to 19 years )
        • Adults
      • By End User :
        • Private Hospitals/ Clinics
          • General Hospitals with Oncology Centers
          • Specialized Hospitals
          • Specialized Clinics
        • Public Hospitals / Clinics
          • General Hospitals with Oncology centers
          • Hospitals
          • Clinics
        • Others
          • Homecare Settings
          • Research Institutes
    • Chile
      • By Chemotherapy Administration :
        • Gravity Chemotherapy Administration
        • Syringe Chemotherapy Administration
        • Pump Chemotherapy Administration
        • Others
      • By Accessories and Consumables :
        • Infusion Sets
        • Venous Access
          • Ports
          • Needle
        • Catheter
          • CVC
          • PIC
        • Needleless Connectors
        • Syringe Filters
        • Software
      • By Age Group :
        • Pediatric
          • Infant ( from birth to 1 year)
          • Children ( 4 to 10 years )
          • Teenager/ Adolescent ( 11 to 19 years )
        • Adults
      • By End User :
        • Private Hospitals/ Clinics
          • General Hospitals with Oncology Centers
          • Specialized Hospitals
          • Specialized Clinics
        • Public Hospitals / Clinics
          • General Hospitals with Oncology centers
          • Hospitals
          • Clinics
        • Others
          • Homecare Settings
          • Research Institutes  
  • Company Profiles
    • Medtronic plc *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • ACE Medical
    • VOGT Medical
    • Becton, Dickinson and Company
    • Smiths Medical, Inc.
    • Samtronic Industria e Comercio LTDA
    • Codan Argus AG
    • Braun Melsungen AG
    • Medical Components, Inc.
    • Fresenius SE & Co. KGaA
    • Baxter International Inc.
    • EuroLife Healthcare Pvt. Ltd.
    • Micrel Medical Devices

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Chemotherapy Administration
      • Market Snapshot, By Accessories and Consumables
      • Market Snapshot, By Age Group
      • Market Snapshot, By End User
      • Market Snapshot, By Country
      • Coherent Opportunity Map (COM)
  3. Latin America Oncology Device Market Insights
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Market Trends
    • PEST Analysis
    • Epidemiology
    • Brand Analysis
    • Regulatory Scenario
    • Collaboration and Acquisitions
    • Reimbursement Scenario
  4. Latin America Oncology Device Market, Impact of COVID-19 Pandemic
    • Pre -COVID Impact
    • Post -COVID-19 Impact
    • Economic Impact
    • Demand and Supply Impact
  5. Latin America Oncology Device Market, By Chemotherapy Administration, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Gravity Chemotherapy Administration
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Syringe Chemotherapy Administration
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Pump Chemotherapy Administration
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Latin America Oncology Device Market, By Accessories and Consumables, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Infusion Sets
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Venous Access
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
            • Ports
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
            • Needles
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Catheter
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
            • CVC
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
            • PIC
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Needleless Connectors
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Syringe Filters
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Software
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Latin America Oncology Device Market, By Age Group, 2016 – , (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017– 2027
      • Segment Trends
        • Pediatric
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016– 2027, (US$ Mn)
            • Infant (from birth to 1 year)
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Children ( 4 to 10 years)
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Teenager/Adolescent (11 to 19 years)
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Adults
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Latin America Oncology Device Market, By End User, 2016-2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017– 2027
      • Segment Trends
        • Private Hospitals / Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • General Hospitals with Oncology Centers
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Specialized Hospitals
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Specialized Clinics
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Public Hospitals / Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • General Hospitals with Oncology Centers
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Specialized Hospitals
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016– 2027, (US$ Mn)
            • Specialized Clinics
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Homecare Settings
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
            • Research Institutes
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2016– 2027, (US$ Mn)
  9. Latin America Oncology Device Market, By Country, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • Brazil
      • Overview
      • Market Size and Forecast, By Chemotherapy Administration, 2016–2027 (US$ Mn), Volume ( Units)
      • Market Size and Forecast, By Accessories and Consumables, 2016–2027 (US$ Mn), Volume (Units)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn), Volume (Units)
      • Market Size and Forecast, By End User, 2016-2027( US$ Mn), Volume (Units)
      • Market Size and Forecast, By Region 2016–2027 (US$ Mn), Volume (Units)
        • South East
        • North East
        • South
        • Mid -West
        • North
    • Mexico
      • Introduction
      • Market Size and Forecast, By Chemotherapy Administration, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Accessories and Consumables, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016-2027( US$ Mn)
    • Chile
      • Introduction
      • Market Size and Forecast, By Chemotherapy Administration, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Accessories and Consumables, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn),
      • Market Size and Forecast, By End User, 2016-2027( US$ Mn)
  10. Competitive Landscape
    • Company Profiles
      • Medtronic plc.*
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ACE Medical
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • VOGT Medical
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Smiths Medical, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Samtronic Industria e Comercio LTDA.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Codan Argus AG
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medical Components, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius SE & Co. KGaA
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Baxter International Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • EuroLife Healthcare Pvt. Ltd.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Micrel Medical Devices
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 33 market data tables and 32 figures on "Latin America Oncology Device Market– Regional forecast to 2027”.

Frequently Asked Questions

The Latin America oncology device market size is estimated to be valued at US$ 31.08 million in 2020 and is expected to exhibit a CAGR of 5.5 % between 2020 and 2027.
The increasing incidence of cancer and the key companies focusing on distribution agreements are the factor expected to drive the Latin America oncology device market.
Gravity chemotherapy administration segment is estimated to hold major market share in Latin America oncology device market over the forecast period.
Adult segment is estimated to hold major market share in 2020, owing increasing prevalence of blood cancer, breast cancer, gastrointestinal cancer, respiratory/lung cancer, and skin cancer.
Brazil is estimated to generate highest revenue share in 2020 in the Latin America oncology device market during the forecast period.
High doses of radiation therapy are used to destroy cancer cells. Side effects caused are damage to healthy cells and tissues near the treatment area and this is a key factor hampering growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner